Requires health insurance and Medicaid coverage for testing and treatments to slow progression of Alzheimer's disease and related disorders.

Summary

The bill orders that all health‑insurance policies and Medicaid plans in New Jersey must pay for medically necessary diagnostic tests and FDA‑approved drugs that are prescribed to slow the progression of Alzheimer’s disease and related disorders. Coverage must be provided at the same level as for any other condition and cannot be limited by step‑therapy requirements. The rule applies to contracts issued or renewed after the law takes effect.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share